Monash Ivf Group Ltd (MVF.AX) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · Australia · ISIN AU000000MVF3

Price
0.74 AUD
Market cap
289.27 m AUD
P/E (2026)
38.96
P/S (2026)
1.07
Dividend yield
3.38 %
Net margin
2.76 %
Return on equity (ROE)
2.98 %
Return on assets (ROA)
1.45 %

Monash Ivf Group Ltd financials

Fiscal year20252026
Revenue271.92 m AUD269.46 m AUD
Gross profit90.31 m AUD61.93 m AUD
Operating income43.41 m AUD20.68 m AUD
EBIT44.17 m AUD20.68 m AUD
Net income25.01 m AUD7.43 m AUD
Diluted EPS – continuing operations0.06 AUD0.02 AUD

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Monash Ivf Group Ltd

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.